OTTAWA, ONTARIO–(Marketwired – March 8, 2018) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in [...]
MONTREAL, QUEBEC–(Marketwired – March 8, 2018) - Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, announced today that [...]
CALGARY, AB and SAN DIEGO, CA–(Marketwired – March 08, 2018) – Oncolytics Biotech®, Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN®, also known as [...]
VANCOUVER, BRITISH COLUMBIA–(Marketwired – March 8, 2018) - (TSX VENTURE:NVH)(FRANKFURT:3NH) “Human heart-in-a-jar” technology recognized by the scientific community for [...]
TUSTIN, Calif., March 07, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to [...]
MONTREAL, QUEBEC–(Marketwired – March 7, 2018) - Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is [...]
SAN FRANCISCO, CA–(Marketwired – March 07, 2018) – VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for [...]
VANCOUVER, BC and BOSTON, MA–(Marketwired – March 07, 2018) – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the “Company”), announced [...]
BOSTON, MA–(Marketwired – March 06, 2018) – Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its [...]